Trevi Therapeutics (TRVI) Short Interest Ratio & Short Volume $7.27 +0.01 (+0.14%) Closing price 04:00 PM EasternExtended Trading$7.18 -0.09 (-1.31%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trevi Therapeutics Short Interest DataTrevi Therapeutics (TRVI) has a short interest of 10.11 million shares. This marks a -0.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.3, indicating that it would take 5.3 days of the average trading volume of 1.87 million shares to cover all short positions.Current Short Interest10,110,000 sharesPrevious Short Interest10,160,000 sharesChange Vs. Previous Month-0.49%Dollar Volume Sold Short$76.03 millionShort Interest Ratio5.3 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares121,780,000 sharesPercentage of Shares Shorted8.30%Today's Trading Volume2,065,152 sharesAverage Trading Volume1,865,473 sharesToday's Volume Vs. Average111% Short Selling Trevi Therapeutics? Sign up to receive the latest short interest report for Trevi Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRVI Short Interest Over TimeTRVI Days to Cover Over TimeTRVI Percentage of Float Shorted Over Time Trevi Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/202510,110,000 shares $76.03 million -0.5%N/A5.3 $7.52 7/31/202510,160,000 shares $75.29 million +2.1%10.2%5.4 $7.41 7/15/20259,950,000 shares $68.26 million +6,352.7%N/A5.4 $6.86 6/30/2025154,200 shares $843.47 thousand -98.0%0.2%1.2 $5.47 6/15/20257,630,000 shares $46.47 million +8.7%8.0%4.4 $6.09 5/31/20257,020,000 shares $45.63 million +2.2%12.1%2.6 $6.50 5/15/20256,870,000 shares $42.53 million -1.2%11.8%3 $6.19 4/30/20256,950,000 shares $48.02 million +17.6%N/A3.1 $6.91 4/15/20255,910,000 shares $36.64 million +7.5%10.2%2.8 $6.20 3/31/20255,500,000 shares $34.60 million +17.5%9.5%2.8 $6.29 Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20254,680,000 shares $31.59 million +23.5%8.1%2.5 $6.75 2/28/20253,790,000 shares $17.13 million -12.5%6.5%1.4 $4.52 2/15/20254,330,000 shares $17.62 million -5.7%7.4%2.5 $4.07 1/31/20254,590,000 shares $18.08 million +11.1%N/A2.7 $3.94 1/15/20254,130,000 shares $15.78 million +6.7%N/A2.4 $3.82 12/31/20243,870,000 shares $15.94 million -17.0%N/A2.3 $4.12 12/15/20244,660,000 shares $19.43 million +230.5%N/A2.8 $4.17 11/30/20241,410,000 shares $4.06 million -19.4%N/A2.8 $2.88 11/15/20241,750,000 shares $4.81 million +1.7%N/A3.7 $2.75 10/31/20241,720,000 shares $5.07 million +13.2%N/A4.4 $2.95 10/15/20241,520,000 shares $4.83 million +0.7%N/A4.6 $3.18 9/30/20241,510,000 shares $5.04 million +8.6%N/A5.7 $3.34 9/15/20241,390,000 shares $4.68 million -10.3%N/A5.4 $3.37 8/31/20241,550,000 shares $4.90 million +3.3%N/A6.8 $3.16 8/15/20241,500,000 shares $4.13 million +16.3%N/A6.6 $2.75 7/31/20241,290,000 shares $4.10 million +1.6%N/A5.6 $3.18 7/15/20241,270,000 shares $3.62 million +32.6%N/A5.6 $2.85 6/30/2024957,600 shares $2.85 million -0.4%N/A4.4 $2.98 6/15/2024961,000 shares $2.55 million +13.1%N/A4.8 $2.65 5/31/2024849,600 shares $2.18 million -13.9%N/A4 $2.57 5/15/2024986,400 shares $2.73 million -6.1%N/A4.2 $2.77 4/30/20241,050,000 shares $3.08 million +16.9%N/A3.6 $2.93 4/15/2024898,400 shares $2.52 million -13.6%N/A3 $2.81 3/31/20241,040,000 shares $3.59 million -2.8%N/A3.5 $3.45 3/15/20241,070,000 shares $3.58 million -13.7%N/A3.8 $3.35 2/29/20241,240,000 shares $3.62 million +4.2%N/A4.2 $2.92 2/15/20241,190,000 shares $2.83 million -13.8%N/A2.7 $2.38 1/31/20241,380,000 shares $1.96 million +11.3%N/A3.6 $1.42 1/15/20241,240,000 shares $1.76 million +6.0%N/A3.2 $1.42 12/31/20231,170,000 shares $1.57 million +15.8%N/A3.1 $1.34What Steve Bannon revealed about Trump’s gold play (Ad)A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.Download the Free Gold Protection Guide to get started now 12/15/20231,010,000 shares $1.29 million -7.3%N/A2.8 $1.28 11/30/20231,090,000 shares $1.23 million -4.4%N/A3.4 $1.13 11/15/20231,140,000 shares $1.57 million -1.7%N/A6.4 $1.38 10/31/20231,160,000 shares $2.06 million -4.9%N/A14 $1.78 10/15/20231,220,000 shares $2.48 million -3.2%N/A18.8 $2.03 9/30/20231,260,000 shares $2.75 million -4.6%N/A17.5 $2.18 9/15/20231,320,000 shares $3.10 million +0.8%N/A14.1 $2.35 8/31/20231,310,000 shares $2.90 million -3.7%N/A6.5 $2.21 8/15/20231,360,000 shares $3.29 million +3.0%N/A4.1 $2.42 7/31/20231,320,000 shares $3.14 million +1.5%N/A3.6 $2.38 7/15/20231,300,000 shares $2.81 million -2.3%N/A3.3 $2.16 6/30/20231,330,000 shares $3.18 million +482.8%N/A3.5 $2.39 6/15/2023228,200 shares $588.76 thousand -5.9%N/A0.6 $2.58 5/31/2023242,600 shares $524.02 thousand -2.1%N/A1 $2.16 5/15/2023247,900 shares $654.46 thousand -11.6%N/A1.5 $2.64 4/30/2023280,300 shares $964.23 thousand +39.2%N/A3.4 $3.44 4/15/2023201,300 shares $380.46 thousand +15.4%N/A3.2 $1.89 3/31/2023174,400 shares $322.64 thousand +51.9%N/A3.6 $1.85 3/15/2023114,800 shares $210.08 thousand +73.2%N/A1.1 $1.83 2/28/202366,300 shares $158.46 thousand -15.8%N/A0.6 $2.39 2/15/202378,700 shares $201.47 thousand -11.6%N/A0.7 $2.56 1/31/202389,000 shares $207.37 thousand -7.0%N/A0.8 $2.33 1/15/202395,700 shares $250.73 thousand +0.8%N/A0.8 $2.62 12/30/202294,900 shares $183.16 thousand -40.6%N/A0.7 $1.93 12/15/2022159,800 shares $356.35 thousand -34.2%N/A0.8 $2.23 11/30/2022242,800 shares $456.46 thousand -16.3%N/A1.2 $1.88 11/15/2022289,900 shares $637.78 thousand -1.9%N/A1.2 $2.20 10/31/2022295,600 shares $585.29 thousand -27.0%N/A1.1 $1.98 10/15/2022405,100 shares $725.13 thousand +264.0%N/A1.3 $1.79 9/30/2022111,300 shares $171.40 thousand +12.5%N/A0.3 $1.54 9/15/202298,900 shares $306.59 thousand -9.9%N/A0.1 $3.10 8/31/2022109,700 shares $348.85 thousand -2.3%0.6%0.1 $3.18 8/15/2022112,300 shares $424.49 thousand -19.1%0.6%0.1 $3.78 7/31/2022138,800 shares $424.73 thousand -29.9%1.1%0.1 $3.06 7/15/2022198,100 shares $691.37 thousand +99.3%1.5%0.1 $3.49 6/30/202299,400 shares $279.31 thousand +10.3%0.8%0.1 $2.81 6/15/202290,100 shares $199.12 thousand -29.7%0.8%0.1 $2.21 5/31/2022128,100 shares $310.00 thousand -48.5%1.1%0.2 $2.42 5/15/2022248,800 shares $549.85 thousand -37.4%2.2%0.2 $2.21 4/30/2022397,500 shares $1.07 million -27.6%11.7%0.3 $2.70 4/15/2022548,900 shares $1.80 million +66.6%3.9%0.5 $3.28 3/31/2022329,400 shares $724.68 thousand -60.4%2.3%0.3 $2.20 3/15/2022832,300 shares $1.22 million +40.9%N/A1.3 $1.46 2/28/2022590,800 shares $378.11 thousand +286.9%4.5%1 $0.64 2/15/2022152,700 shares $79.25 thousand +95.5%1.2%0.6 $0.52 1/31/202278,100 shares $49.80 thousand +4.3%0.8%0.3 $0.64 1/15/202274,900 shares $53.83 thousand -34.9%0.8%0.3 $0.72 12/31/2021115,100 shares $90.03 thousand +16.6%1.2%0.2 $0.78 12/15/202198,700 shares $70.77 thousand +16.7%1.0%0.2 $0.72 11/30/202184,600 shares $84.14 thousand -42.2%1.2%0.2 $0.99What Steve Bannon revealed about Trump’s gold play (Ad)A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.Download the Free Gold Protection Guide to get started now 11/15/2021146,400 shares $161.04 thousand -8.3%2.1%0.3 $1.10 10/29/2021159,700 shares $187.65 thousand +14.3%2.8%0.4 $1.18 10/15/2021139,700 shares $180.21 thousand +25.9%2.4%0.4 $1.29 9/30/2021111,000 shares $155.40 thousand +26.1%1.5%0.4 $1.40 9/15/202188,000 shares $123.20 thousand +43.1%1.2%1.5 $1.40 8/31/202161,500 shares $102.09 thousand -23.8%0.8%0.8 $1.66 8/13/202180,700 shares $162.61 thousand +11.3%1.1%1.2 $2.02 7/30/202172,500 shares $137.75 thousand -28.0%1.1%1.1 $1.90 7/15/2021100,700 shares $196.37 thousand +16.7%1.6%1.4 $1.95 6/30/202186,300 shares $194.18 thousand -1.9%1.3%1.3 $2.25 6/15/202188,000 shares $196.24 thousand -6.1%1.5%1.5 $2.23 5/28/202193,700 shares $199.58 thousand +11.7%1.6%2.5 $2.13 5/14/202183,900 shares $168.64 thousand +36.0%1.4%1.8 $2.01 4/30/202161,700 shares $145.00 thousand -30.6%1.0%1 $2.35 4/15/202188,900 shares $221.81 thousand +31.7%1.5%1 $2.50 3/31/202167,500 shares $193.05 thousand -46.5%1.4%0.7 $2.86 3/15/2021126,200 shares $340.74 thousand +132.4%2.9%1.1 $2.70 2/26/202154,300 shares $155.30 thousand -16.3%1.2%0.5 $2.86 2/12/202164,900 shares $205.73 thousand +2.0%1.5%0.6 $3.17 1/29/202163,600 shares $192.71 thousand +35.6%1.5%0.7 $3.03 1/15/202146,900 shares $140.70 thousand +4.9%1.1%0.7 $3.00 12/31/202044,700 shares $113.54 thousand -0.9%1.0%1 $2.54 12/15/202045,100 shares $132.14 thousand +14.5%1.1%1.3 $2.93 11/30/202039,400 shares $121.55 thousand -12.4%0.9%1.7 $3.09 11/15/202045,000 shares $151.20 thousand -5.9%1.6%1.6 $3.36 10/30/202047,800 shares $152.00 thousand +13.8%1.7%1.1 $3.18 10/15/202042,000 shares $153.30 thousand -40.8%1.5%0.5 $3.65 9/30/202070,900 shares $285.73 thousand -9.6%2.5%0.8 $4.03 9/15/202078,400 shares $301.84 thousand +185.1%2.7%0.8 $3.85 TRVI Short Interest - Frequently Asked Questions What is Trevi Therapeutics' current short interest? Short interest is the volume of Trevi Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 10,110,000 shares of TRVI short. Learn More on Trevi Therapeutics' current short interest. What is a good short interest ratio for Trevi Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRVI shares currently have a short interest ratio of 5.0. Learn More on Trevi Therapeutics's short interest ratio. Which institutional investors are shorting Trevi Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trevi Therapeutics: LMR Partners LLP, Group One Trading LLC, Jane Street Group LLC, Caption Management LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Trevi Therapeutics' short interest increasing or decreasing? Trevi Therapeutics saw a decrease in short interest in the month of August. As of August 15th, there was short interest totaling 10,110,000 shares, a decrease of 0.5% from the previous total of 10,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Trevi Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trevi Therapeutics: Apellis Pharmaceuticals, Inc. (16.05%), Scholar Rock Holding Corporation (16.09%), Arrowhead Pharmaceuticals, Inc. (9.39%), Viking Therapeutics, Inc. (24.47%), AMNEAL PHARMACEUTICALS, INC. (3.30%), Xenon Pharmaceuticals Inc. (8.94%), Kymera Therapeutics, Inc. (10.64%), Crinetics Pharmaceuticals, Inc. (14.76%), Ultragenyx Pharmaceutical Inc. (8.73%), Bausch Health Cos Inc. (2.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Trevi Therapeutics stock? Short selling TRVI is an investing strategy that aims to generate trading profit from Trevi Therapeutics as its price is falling. TRVI shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trevi Therapeutics? A short squeeze for Trevi Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVI, which in turn drives the price of the stock up even further. How often is Trevi Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVI, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies APLS Short Interest Data SRRK Short Interest Data ARWR Short Interest Data VKTX Short Interest Data AMRX Short Interest Data XENE Short Interest Data KYMR Short Interest Data CRNX Short Interest Data RARE Short Interest Data BHC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRVI) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVI Stock Alerts